DrugPatentWatch Database Preview
Hikma Company Profile
» See Plans and Pricing
What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?
HIKMA has three hundred and forty approved drugs.
There are five US patents protecting HIKMA drugs. There are three tentative approvals on HIKMA drugs.
Summary for Hikma
| US Patents: | 5 |
| Tradenames: | 238 |
| Ingredients: | 219 |
| NDAs: | 340 |
| Patent Litigation for Hikma: | See patent lawsuits for Hikma |
| PTAB Cases with Hikma as petitioner: | See PTAB cases with Hikma as petitioner |
Drugs and US Patents for Hikma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Farmaceutica | CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065238-001 | Mar 12, 2010 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Hikma Pharms | PENICILLIN V POTASSIUM | penicillin v potassium | TABLET;ORAL | 090549-002 | Oct 11, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma | OXYMORPHONE HYDROCHLORIDE | oxymorphone hydrochloride | TABLET;ORAL | 090964-002 | Sep 27, 2010 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | TABLET;ORAL | 200652-001 | May 4, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma | DOXERCALCIFEROL | doxercalciferol | CAPSULE;ORAL | 091433-001 | Sep 23, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma Intl Pharms | GLYCOPYRROLATE | glycopyrrolate | TABLET;ORAL | 040836-002 | Mar 5, 2009 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hikma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-001 | Approved Prior to Jan 1, 1982 | 4,017,616 | Start Trial |
| Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-002 | Approved Prior to Jan 1, 1982 | 4,017,616 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HIKMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 0.6 mg | ➤ Subscribe | 2016-06-10 |
| ➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
| ➤ Subscribe | Tablets | 1 mg | ➤ Subscribe | 2009-08-14 |
| ➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
